Ambulatory infusion centers provide convenient medical care outside of hospitals. They offer IV therapy, hydration treatments, pharmaceutical injections, and other services to patients on an outpatient basis. This eliminates the need for costly overnight hospital stays. The services help reduce illness symptoms, prevent complications, and improve quality of life for people with chronic conditions like cancer, congestive heart failure, Crohn's disease, and rheumatoid arthritis. The global Ambulatory Infusion Center Market is estimated to be valued at US$67.84 Bn in 2024 and is expected to exhibit a CAGR of 9.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing demand for convenience and cost-effective treatments has been a key growth driver for the ambulatory infusion center market. People prefer receiving medical services at alternate sites outside hospitals as it is more flexible and affordable. Ambulatory infusion centers allow patients to get IV therapy and other infusions done without staying overnight at hospitals. This saves significant costs for patients, insurers, and the overall healthcare system. As chronic diseases rise worldwide, the demand for such affordable non-hospital care options is surging. This rising demand is expected to propel the ambulatory infusion center market growth over the forecast period.
Segment Analysis
Ambulatory infusion center market can be segmented into the following types - Oncology Infusion Centers, Pediatric Infusion Centers, Antibiotic Infusion Centers, Hydration Therapy Infusion Centers, IV Therapy Infusion Centers, and Pain Management Infusion Centers. Oncology infusion centers dominate the segment accounting for over 30% of the overall market share. Cancer continues to be one of the leading causes of mortality, therefore the demand for chemotherapy and other cancer related treatments which requires less hospital stays at affordable costs is driving the growth of oncology infusion centers.
Key Takeaways
The global Ambulatory Infusion Center market is expected to witness high growth over the forecast period of 2024 to 2031.
Regional analysis suggests that North America holds the largest market share currently due to high healthcare expenditure and early adoption rates of technologically advanced products. However, Asia Pacific region is poised to grow at the fastest pace attributed to increasing incidence of chronic diseases and presence of huge target patient pool in the region.
Key players operating in the Ambulatory Infusion Center market are Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, CHI Health, Accredo Health, PharMerica, and Cleveland Clinic. The market continues to witness high consolidation activities as large players are focusing on acquisitions to strengthen their product portfolio and geographic presence. For instance, in 2022, UnitedHealth Group acquired Signify Health to expand its value-based care capabilities.
No comments:
Post a Comment